These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6398687)

  • 1. Protective properties of peptidoglycan associated protein of Shigella flexneri.
    Mulczyk M; Adamus G; Witkowska D
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):631-5. PubMed ID: 6398687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on specificity of protection induced by immunization with outer membrane proteins of Shigella.
    Witkowska D; Mulczyk M; Adamus G
    Arch Immunol Ther Exp (Warsz); 1985; 33(5):625-8. PubMed ID: 3914866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of immunity by means of spleen cells from mice immunized with outer membrane proteins of Shigella flexneri.
    Witkowska D; Mleczko J; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1985; 33(5):629-35. PubMed ID: 3914867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral response in mice immunized with outer membrane proteins of Shigella flexneri.
    Witkowska D; Czarny A; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1986; 34(5-6):499-504. PubMed ID: 3296993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic and protective properties of outer membrane proteins of Hafnia alvei.
    Witkowska D; Czarny A; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):387-93. PubMed ID: 2130804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on nonspecific protection induced with OMP of Shigella flexneri and other genera of Enterobacteriaceae.
    Czarny A; Witkowska D; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1990; 38(5-6):353-7. PubMed ID: 2130800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on virulence of Shigella flexneri. Protective effect of outer membrane proteins.
    Mulczyk M; Adamus G; Witkowska D; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):85-90. PubMed ID: 7025793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of outer membrane proteins from Shigella on humoral immunity induced in mice by SRBC.
    Czarny A; Witkowska D; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1992; 40(2):129-34. PubMed ID: 1299171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a.
    Pore D; Chowdhury P; Mahata N; Pal A; Yamasaki S; Mahalanabis D; Chakrabarti MK
    Vaccine; 2009 Sep; 27(42):5855-64. PubMed ID: 19660587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity to Shigella outer membrane proteins in mice.
    Mulczyk M; Witkowska D; Mleczko J
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):763-8. PubMed ID: 2977277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of outer membrane proteins (OMP) of Shigella on interleukin 2 (IL-2) production by spleen cells of mice.
    Czarny A; Witkowska D; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):159-61. PubMed ID: 7487346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Shigella flexneri 2a 34 kDa outer membrane protein in induction of protective immune response.
    Mukhopadhaya A; Mahalanabis D; Chakrabarti MK
    Vaccine; 2006 Aug; 24(33-34):6028-36. PubMed ID: 16765491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some biological properties of outer membrane proteins of Shigella.
    Witkowska D; Czarny A; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):759-62. PubMed ID: 3334007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-rEPAsucc conjugate vaccines in one- to four-year-old children.
    Passwell JH; Ashkenazi S; Harlev E; Miron D; Ramon R; Farzam N; Lerner-Geva L; Levi Y; Chu C; Shiloach J; Robbins JB; Schneerson R;
    Pediatr Infect Dis J; 2003 Aug; 22(8):701-6. PubMed ID: 12913770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phagocytic and bactericidal properties of macrophages of mice immunized with outer membrane proteins (OMP) of Shigella.
    Czarny A; Witkowska D; Mulczyk M
    Arch Immunol Ther Exp (Warsz); 1988; 36(6):701-9. PubMed ID: 3254119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenicity and antigenic relatedness of the outer membrane proteins of Shigella species.
    Roy S; Das AB; Biswas T
    Microbios; 1994; 79(318):55-64. PubMed ID: 7521507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine potential for inactivated shigellae.
    Osorio M; Bray MD; Walker RI
    Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.